VACCINATION OF PATIENTS WITH ONCOLOGY DISEASES AGAINST MEASLES AND MUMPS

Abstract. One hundred and seven children (45 girls and 62 boys) in the age of 20 months — 14 years old (mean 9,62±0,37) suffered from acute lymphoblast leukosis and solid tumors in history have been examined in the clinic of Research Institute of children infections of FMBA. The vaccination history...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	S. M. Kharit, T. V. Cherniaeva, E. V. Cherniaeva, N. K. Brusov
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2014
Materias:	vaccination against measles and mumps oncology diseases children specific antibodies Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/9ff6f23936f444a6b7d8dddb8ef11b26
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9ff6f23936f444a6b7d8dddb8ef11b26
record_format	dspace
spelling	oai:doaj.org-article:9ff6f23936f444a6b7d8dddb8ef11b262021-11-22T07:09:45ZVACCINATION OF PATIENTS WITH ONCOLOGY DISEASES AGAINST MEASLES AND MUMPS2220-76192313-739810.15789/2220-7619-2011-1-85-91https://doaj.org/article/9ff6f23936f444a6b7d8dddb8ef11b262014-06-01T00:00:00Zhttps://www.iimmun.ru/iimm/article/view/32https://doaj.org/toc/2220-7619https://doaj.org/toc/2313-7398Abstract. One hundred and seven children (45 girls and 62 boys) in the age of 20 months — 14 years old (mean 9,62±0,37) suffered from acute lymphoblast leukosis and solid tumors in history have been examined in the clinic of Research Institute of children infections of FMBA. The vaccination history was studied in all children and the titers of specific antibodies to measles and mumps viruses as well as immune status were determined. 83,8% and 85,4% of studied children had no protection against measles and mumps respectively or had low titers of antibodies. Immunological examination of these children conducted within 4 months after finishing of therapy revealed absence of immunodeficiency. It gave opportunities to vaccinate or revaccinate these children against mentioned infections. Fifty three children were immunized against measles and 47 — against mumps. Application of live vaccines was safe because majority of vaccinated against measles (81,1%) and mumps (82,9%) children had mild vaccination process. It was established that to increase immunological efficacy of vaccination using of polyoxidony during 5 days before vaccination and 5 days after vaccination is reasonable.S. M. KharitT. V. CherniaevaE. V. CherniaevaN. K. BrusovSankt-Peterburg : NIIÈM imeni Pasteraarticlevaccination against measles and mumpsoncology diseaseschildrenspecific antibodiesInfectious and parasitic diseasesRC109-216RUInfekciâ i Immunitet, Vol 1, Iss 1, Pp 85-91 (2014)
institution	DOAJ
collection	DOAJ
language	RU
topic	vaccination against measles and mumps oncology diseases children specific antibodies Infectious and parasitic diseases RC109-216
spellingShingle	vaccination against measles and mumps oncology diseases children specific antibodies Infectious and parasitic diseases RC109-216 S. M. Kharit T. V. Cherniaeva E. V. Cherniaeva N. K. Brusov VACCINATION OF PATIENTS WITH ONCOLOGY DISEASES AGAINST MEASLES AND MUMPS
description	Abstract. One hundred and seven children (45 girls and 62 boys) in the age of 20 months — 14 years old (mean 9,62±0,37) suffered from acute lymphoblast leukosis and solid tumors in history have been examined in the clinic of Research Institute of children infections of FMBA. The vaccination history was studied in all children and the titers of specific antibodies to measles and mumps viruses as well as immune status were determined. 83,8% and 85,4% of studied children had no protection against measles and mumps respectively or had low titers of antibodies. Immunological examination of these children conducted within 4 months after finishing of therapy revealed absence of immunodeficiency. It gave opportunities to vaccinate or revaccinate these children against mentioned infections. Fifty three children were immunized against measles and 47 — against mumps. Application of live vaccines was safe because majority of vaccinated against measles (81,1%) and mumps (82,9%) children had mild vaccination process. It was established that to increase immunological efficacy of vaccination using of polyoxidony during 5 days before vaccination and 5 days after vaccination is reasonable.
format	article
author	S. M. Kharit T. V. Cherniaeva E. V. Cherniaeva N. K. Brusov
author_facet	S. M. Kharit T. V. Cherniaeva E. V. Cherniaeva N. K. Brusov
author_sort	S. M. Kharit
title	VACCINATION OF PATIENTS WITH ONCOLOGY DISEASES AGAINST MEASLES AND MUMPS
title_short	VACCINATION OF PATIENTS WITH ONCOLOGY DISEASES AGAINST MEASLES AND MUMPS
title_full	VACCINATION OF PATIENTS WITH ONCOLOGY DISEASES AGAINST MEASLES AND MUMPS
title_fullStr	VACCINATION OF PATIENTS WITH ONCOLOGY DISEASES AGAINST MEASLES AND MUMPS
title_full_unstemmed	VACCINATION OF PATIENTS WITH ONCOLOGY DISEASES AGAINST MEASLES AND MUMPS
title_sort	vaccination of patients with oncology diseases against measles and mumps
publisher	Sankt-Peterburg : NIIÈM imeni Pastera
publishDate	2014
url	https://doaj.org/article/9ff6f23936f444a6b7d8dddb8ef11b26
work_keys_str_mv	AT smkharit vaccinationofpatientswithoncologydiseasesagainstmeaslesandmumps AT tvcherniaeva vaccinationofpatientswithoncologydiseasesagainstmeaslesandmumps AT evcherniaeva vaccinationofpatientswithoncologydiseasesagainstmeaslesandmumps AT nkbrusov vaccinationofpatientswithoncologydiseasesagainstmeaslesandmumps
_version_	1718418057535160320

VACCINATION OF PATIENTS WITH ONCOLOGY DISEASES AGAINST MEASLES AND MUMPS

Ejemplares similares